MOACM
AXSM icon

Mutual of America Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Mutual of America Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.09M Sell
41,936
-104
-0.2% -$18K 0.08% 292
2025
Q4 		$7.68M Sell
42,040
-266
-0.6% -$37.1K 0.08% 274
2025
Q3 		$5.14M Sell
42,306
-997
-2% -$112K 0.05% 429
2025
Q2 		$4.52M Buy
43,303
+3,680
+9% +$390K 0.05% 476
2025
Q1 		$4.62M Buy
39,623
+136
+0.3% +$15.5K 0.05% 455
2024
Q4 		$3.34M Sell
39,487
-35
-0.1% -$3.22K 0.04% 648
2024
Q3 		$3.55M Sell
39,522
-371
-0.9% -$32.4K 0.04% 646
2024
Q2 		$3.21M Sell
39,893
-1,727
-4% -$128K 0.04% 677
2024
Q1 		$3.32M Buy
41,620
+7,042
+20% +$591K 0.04% 679
2023
Q4 		$2.75M Sell
34,578
-1,590
-4% -$106K 0.03% 758
2023
Q3 		$2.53M Sell
36,168
-2,152
-6% -$161K 0.03% 755
2023
Q2 		$2.75M Sell
38,320
-2,925
-7% -$216K 0.03% 774
2023
Q1 		$2.54M Buy
41,245
+1,993
+5% +$131K 0.03% 804
2022
Q4 		$3.03M Buy
39,252
+17,456
+80% +$1.04M 0.04% 717
2022
Q3 		$973K Buy
+21,796
New +$1.09M 0.01% 1028

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mutual of America Capital Management's AXSM Position: Q1 2026 in Review

Mutual of America Capital Management reduced its Axsome Therapeutics (AXSM) stake by 0.25% in Q1 2026, selling an estimated $18K and leaving 41,936 shares worth $7.09M. The position accounts for 0.08% of the portfolio, ranked #292.

Mutual of America Capital Management first reported a position in AXSM in Q3 2022 and has held it in 15 quarters since. The position peaked at $7.68M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Mutual of America Capital Management held 41,936 shares of Axsome Therapeutics worth $7.09M as of Q1 2026.
  • Mutual of America Capital Management sold 104 Axsome Therapeutics shares in Q1 2026, an estimated $18K.
  • Axsome Therapeutics made up 0.08% of Mutual of America Capital Management's portfolio in Q1 2026, its #292 holding.
  • Mutual of America Capital Management first reported a position in Axsome Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Mutual of America Capital Management's Axsome Therapeutics position peaked at $7.68M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.